AstraZeneca PLC
LSE:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
LSE:AZN
Watchlist
Price: 12 296 GBX -0.87%
Updated: May 27, 2024

AstraZeneca PLC
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AstraZeneca PLC
Long-Term Debt Peer Comparison

Comparables:
GSK
VRNA
INDV
HIK
DPH

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
AstraZeneca PLC
LSE:AZN
Long-Term Debt
$28.2B
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
14%
GlaxoSmithKline PLC
LSE:GSK
Long-Term Debt
£15.2B
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
0%
Verona Pharma PLC
NASDAQ:VRNA
Long-Term Debt
$48.4m
CAGR 3-Years
119%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Long-Term Debt
$267m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Long-Term Debt
$1B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
14%
Dechra Pharmaceuticals PLC
LSE:DPH
Long-Term Debt
£500.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
17%

See Also

What is AstraZeneca PLC's Long-Term Debt?
Long-Term Debt
28.2B USD

Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Long-Term Debt amounts to 28.2B USD.

What is AstraZeneca PLC's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
14%

Over the last year, the Long-Term Debt growth was 2%. The average annual Long-Term Debt growth rates for AstraZeneca PLC have been 16% over the past three years , 10% over the past five years , and 14% over the past ten years .